0
Clinical Investigations: SURGERY |

Evolution of the Postoperative Pericardial Effusion After Day 15*: The Problem of the Late Tamponade

Philippe Meurin, MD; Hélène Weber, MD; Nathalie Renaud, MD; Fabrice Larrazet, MD; Jean Yves Tabet, MD; Pierre Demolis, MD, PhD; Ahmed Ben Driss, MD, PhD
Author and Funding Information

*From the Centre de Réadaptation Cardiaque de la Brie (Drs. Meurin, Weber, Renaud, Tabet, and Ben Driss), Villeneuve Saint Denis; Institut Mutualiste Montsouris (Dr. Larrazet), Paris; and Unité de Recherche Clinique (Dr. Demolis), Centre Hospitalier Universitaire, Bicêtre, France.

Correspondence to: Philippe Meurin, MD, Centre de Réadaptation Cardiaque de la Brie, 27, rue Sainte Christine, 77174 Villeneuve Saint Denis, France; e-mail: philippemeurin@hotmail.com



Chest. 2004;125(6):2182-2187. doi:10.1378/chest.125.6.2182
Text Size: A A A
Published online

Study objectives: To evaluate, through clinical and transthoracic echocardiography (TTE) follow-up, the natural history of persistent pericardial effusion (PE) after postoperative day 15 in patients who were given and were not given anticoagulant therapy.

Design and patients: We retrospectively studied a cohort of 1,277 patients who were hospitalized between May 1997 and May 1999 in our center a mean (± SD) time period of 15 ± 3 days after undergoing coronary artery bypass graft (CABG) surgery (856 patients) or valve replacement (VR) surgery (421 patients).

Measurements: TTE was performed on mean (± SD) postoperative day 20 ± 1 (TTE1) and postoperative day 30 ± 2 (TTE2). PE severity was classified on a scale from grade 1 to grade 4.

Results: On postoperative day 20 ± 1, PE was present in 22% of the 1,277 patients and was more frequent after patients underwent CABG surgery than after undergoing VR surgery (25% vs 17%, respectively; p < 0.01). On postoperative day 30 ± 2, the overall incidence of late tamponade in patients with PE was 4%. The incidence increased with the severity grade of PE at TTE1 (p < 0.001). The negative predictive value of a severity grade < 2 at TTE1 for late tamponade was 100%. Late tamponade incidence was higher after VR surgery than after CABG surgery (11% vs 2%, respectively; p < 0.01), and was higher in patients who had received anticoagulation therapy than in those who had not (8% vs 2%, respectively; p < 0.05).

Conclusion: Persisting PE is common after postoperative day 15 and is more frequent after undergoing CABG surgery than after undergoing VR surgery. The incidence of late tamponade is usually underestimated, and it increases with the presence of VR, anticoagulation therapy, and/or higher postoperative TTE severity grade. Our data suggest that only patients with a PE severity grade of ≥ 2 (< 10% of patients) require TTE follow-up after postoperative day 20.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543